Entire PTCH1 deletion is a common event in point mutation-negative cases with nevoid basal cell carcinoma syndrome in Japan

Clinical Genetics

Volumn 79, Issue 2, 2011, Pages 196-198

  Nagao, K ^a   Fujii, K ^b   Saito, K ^c   Sugita, K ^d   Endo, M ^b   Motojima, T ^e   Hatsuse, H ^a   Miyashita, T ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY   (Japan)

^e Motojima General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN PATCHED 1;

BASAL CELL NEVUS SYNDROME; COMPARATIVE GENOMIC HYBRIDIZATION; EXON; GENE DELETION; HETEROZYGOSITY LOSS; HUMAN; LETTER; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; BASAL CELL NEVUS SYNDROME; CHILD; CHILD, PRESCHOOL; FEMALE; GENE DELETION; HUMANS; INFANT; JAPAN; MALE; RECEPTORS, CELL SURFACE;

EID: 78650915943     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01527.x     Document Type: Letter

References (14)

1. Gorlin RJ. Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore) 1987: 66: 98-113.
2. Johnson RL, Rothman AL, Xie J et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996: 272: 1668-1671.
3. Hahn H, Wicking C, Zaphiropoulous PG et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996: 85: 841-851.
4. Gailani MR, Stahle-Backdahl M, Leffell DJ et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 1996: 14: 78-81.
5. Unden AB, Holmberg E, Lundh-Rozell B et al. Mutations in the human homologue of Drosophila patched (PTCH) in basal cell carcinomas and the Gorlin syndrome: different in vivo mechanisms of PTCH inactivation. Cancer Res 1996: 56: 4562-4565.
6. Fujii K, Kohno Y, Sugita K et al. Mutations in the human homologue of Drosophila patched in Japanese nevoid basal cell carcinoma syndrome patients. Hum Mutat 2003: 21: 451-452.
7. Marsh A, Wicking C, Wainwright B, Chenevix-Trench G. DHPLC analysis of patients with Nevoid Basal Cell Carcinoma Syndrome reveals novel PTCH missense mutations in the sterol-sensing domain. Hum Mutat 2005: 26: 283.
8. Lindström E, Shimokawa T, Toftgård R, Zaphiropoulos PG. PTCH mutations: distribution and analyses. Hum Mutat 2006: 27: 215-219.
9. Fujii K, Ishikawa S, Uchikawa H et al. High-density oligonucleotide array with sub-kilobase resolution reveals breakpoint information of submicroscopic deletions in nevoid basal cell carcinoma syndrome. Hum Genet 2007: 122: 459-466.
10. Takahashi C, Kanazawa N, Yoshikawa Y et al. Germline PTCH1 mutations in Japanese basal cell nevus syndrome patients. J Hum Genet 2009: 54: 403-408.
11. Kurotaki N, Harada N, Shimokawa O et al. Fifty microdeletions among 112 cases of Sotos syndrome: low copy repeats possibly mediate the common deletion. Hum Mutat 2003: 22: 378-387.
12. Dorschner MO, Sybert VP, Weaver M, Pletcher BA, Stephens K. NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. Hum Mol Genet 2000: 9: 35-46.
13. Fan Z, Li J, Du J et al. A missense mutation in PTCH2 underlies dominantly inherited NBCCS in a Chinese family. J Med Genet 2008: 45: 303-308.
14. Pastorino L, Ghiorzo P, Nasti S et al. Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet A 2009: 149A: 1539-1543.